Key result
Surgical resection of spinal cellular myxomas shows no recurrence at 6 months in two cases.
Why the study?
Spinal intramuscular myxomas are rare and can be difficult to distinguish from other tumours based on imaging alone, necessitating detailed radiological and histological analysis.
Case Report (n=2)
Surgical resection of spinal myxomas appears effective with no recurrence observed at 6 months, though histological analysis is required for definitive diagnosis.
Answers are grounded in this paper and cite their sources.
Resection may be feasible short-term in rare spinal cellular myxomas; leaves open need for longer follow-up and larger series.
Intramuscular myxomas are rare, benign mesenchymal tumours, occurring predominantly in large skeletal muscles as large, slow-growing and painless masses. Spinal occurrence is rare, and may present incidentally, or diagnosed via localized symptoms secondary to local infiltration of surrounding structures. Differential diagnosis based on imaging includes sarcomas, meningiomas and lipomas. We discuss two contrasting cases presenting with well-circumscribed cystic paraspinal lesions indicative of an infiltrative tumour and discuss the radiological and histological differences that distinguish myxomas from similar tumours. Surgical resection of the tumour was performed in both cases, however one patient required surgical fixation due to bony erosion secondary to tumour infiltration. Immuno-histopathological analysis confirmed the diagnosis of a cellular myxoma. Follow up imaging at 6 months confirmed no symptomatic or tumour recurrence in both cases. Histological analysis is the definitive means for diagnosis to differentiate myxomas from other tumours. Recurrence is rare if full resection is achieved.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2022) conducted a case report in Spinal myxomas (n=2). Surgical resection was evaluated on Symptomatic or tumour recurrence. Surgical resection of spinal cellular myxomas resulted in no symptomatic or tumour recurrence at 6 months follow-up in two cases.
Synapse has enriched 10 related papers. Consider them for comparative context: